Kathy Yi's Net Worth
$737 Thousand
Who is Kathy Yi?
Kathy Yi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SANGAMO THERAPEUTICS, INC, Theseus Pharmaceuticals, Inc., and Cerevel Therapeutics Holdings, Inc..
SEC CIK
Kathy Yi's CIK is 0001697802
Past Insider Trading and Trends
2018 was Kathy Yi's most active year for acquiring shares with 12 total transactions. Kathy Yi's most active month to acquire stocks was the month of January. 2018 was Kathy Yi's most active year for disposing of shares, totalling 20 transactions. Kathy Yi's most active month to dispose stocks was the month of February. 2019 saw Kathy Yi paying a total of $113,750.00 for 159,750 shares, this is the most they've acquired in one year. In 2018 Kathy Yi cashed out on 100,000 shares for a total of $783,387.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.28 | -$27,250.00 | 25.51K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$8.33 | -$37,800.00 | 25.51K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$7.28 | -$27,250.00 | 25.51K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$7.28 | -$27,250.00 | 25.51K |
Scheduled
|
Mar 1
| ||
Form 4
| +307.41% | 19.25K |
—
|
—
| 25.51K |
Feb 25
| |||
Form 4
| -13.63% | -988.00 |
$11.10 | -$10,966.80 | 6.26K |
Jan 24
| |||
Form 4
|
—
|
0
|
$7.80 | -$32,450.00 | 7.25K |
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$7.99 | -$34,450.00 | 7.25K |
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
$7.28 | -$27,250.00 | 7.25K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$9.26 | -$47,100.00 | 7.25K |
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$9.61 | -$50,534.50 | 7.25K |
Scheduled
|
Sep 17
| ||
Form 4
|
—
|
0
|
$9.97 | -$54,201.50 | 7.25K |
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$9.66 | -$51,110.00 | 7.25K |
Scheduled
|
Jul 16
| ||
Form 4
|
—
|
0
|
$10.11 | -$55,615.00 | 7.25K |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$9.97 | -$54,170.00 | 7.25K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$12.19 | -$76,394.00 | 7.25K |
Scheduled
|
Apr 16
| ||
Form 4
|
—
|
0
|
$15.06 | -$105,062.00 | 7.25K |
Scheduled
|
Mar 15
| ||
Form 4
|
∞
| 7.25K |
—
|
—
| 7.25K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerevel Therapeutics Holdings, Inc. (CERE) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||